title: Phenylarsine oxide inhibits ex vivo HIV-1 expression.
abstract: Phenylarsine oxide (PAO), which is described as an inhibitor of tyrosine phosphatase activity, inhibits H2O2 release from human peripheral blood mononuclear cells (PBMCs) as measured by electrochemistry. Since human immunodeficiency virus type 1 (HIV-1) replication is known to be favored under oxidative stress conditions, ex vivo experiments using uninfected PBMCs, primary monocytes or a latently infected promonocytic U1 cell line show that HIV-1 replication and reactivation, monitored by p24 antigen measurement, are inhibited by PAO in a time- and concentration-dependent manner. These observations can be linked with the inhibition of NF-kappa B activation when uninfected monocytes are induced by either tumor necrosis factor alpha (TNF-alpha) phorbol 12-myristate 13-acetate (PMA) or lipopolysaccharide (LPS).
authors.affiliation: URA 1679 and UPR42 CNRS, Ecole Normale Supérieure, Paris, France.
authors.forename: S
authors.initials: S
authors.lastname: Arbault
authors.forename: M
authors.initials: M
authors.lastname: Edeas
authors.forename: S
authors.initials: S
authors.lastname: Legrand-Poels
authors.forename: N
authors.initials: N
authors.lastname: Sojic
authors.forename: C
authors.initials: C
authors.lastname: Amatore
authors.forename: J
authors.initials: J
authors.lastname: Piette
authors.forename: M
authors.initials: M
authors.lastname: Best-Belpomme
authors.forename: A
authors.initials: A
authors.lastname: Lindenbaum
authors.forename: M
authors.initials: M
authors.lastname: Vuillaume
mesh_terms: D001152:Arsenicals / Q000494:pharmacology*; D002460:Cell Line; D004791:Enzyme Inhibitors / Q000494:pharmacology; D016655:HIV Core Protein p24 / Q000096:biosynthesis; D015497:HIV-1 / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D006861:Hydrogen Peroxide / Q000032:analysis; D008070:Lipopolysaccharides / Q000494:pharmacology; D009000:Monocytes / Q000187:drug effects / Q000502:physiology* / Q000821:virology*; D016328:NF-kappa B / Q000378:metabolism; D018384:Oxidative Stress; D054562:Protein Tyrosine Phosphatase, Non-Receptor Type 1; D017027:Protein Tyrosine Phosphatases / Q000037:antagonists & inhibitors; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology; D014779:Virus Replication / Q000187:drug effects*
chemical_list: D001152:Arsenicals; D004791:Enzyme Inhibitors; D016655:HIV Core Protein p24; D008070:Lipopolysaccharides; D016328:NF-kappa B; D014409:Tumor Necrosis Factor-alpha; C029341:oxophenylarsine; D006861:Hydrogen Peroxide; D054562:Protein Tyrosine Phosphatase, Non-Receptor Type 1; D017027:Protein Tyrosine Phosphatases; D013755:Tetradecanoylphorbol Acetate